Inventor
Kevin Yang
Inventor
San Gabriel, CA, US
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes12%
C07CAcyclic or carbocyclic compounds11%
C07BGeneral methods of organic chemistry8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
C04BLime, magnesia1%
G01CMeasuring distances, levels or bearings1%
G06QInformation and communication technology [ict] specially adapted for administrative, commercial, financial, managerial or supervisory purposes1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
10,532,042KRAS G12C inhibitors and methods of using the same202010,221,162Triazole agonists of the APJ receptor20199,868,721'Triazole agonists of the APJ receptor'20189,845,310Intermediates for preparing triazole agonists of the APJ receptor20179,751,864'Methods for preparing triazole agonists of the APJ receptor'20179,745,286'Triazole agonists of the APJ receptor'20179,656,998'Intermediates for preparing triazole agonists of the APJ receptor'20179,656,997'Triazole agonists of the APJ receptor'20179,573,936'Triazole agonists of the APJ receptor'20179,066,954'Fused heterocyclic derivatives and methods of use'20158,772,480'Inhibitors of PI3 kinase and/or mTOR'20148,729,074'Inhibitors of PI3 kinase'20148,685,983'Method of treating cancer with substituted amide derivatives'20148,524,900'Fused heterocyclic derivatives and methods of use'20138,431,563'Compounds that interact with glucokinase regulatory protein for the treatment of diabetes'20138,415,376'Inhibitors of PI3 kinase'20138,314,087'Nitrogen-containing heterocyclyl ketones and methods of use'20128,088,794'Substituted amide derivatives and methods of use'20127,928,140'Benzothiazole PI3 kinase modulators for cancer treatment'20117,662,811'1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use'20107,425,631'Compounds and methods of use'20087,414,134'B1 bradykinin receptor antagonists'20087,393,852'Piperazine derivatives and methods of use'20087,320,992'Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use'20087,307,088'Substituted anthranilic amide derivatives and methods of use'20077,199,244'Cyclic amine derivatives and methods of use'20077,196,104'Thiazolyl urea compounds and methods of uses'20076,878,714'Substituted alkylamine derivatives and methods of use'20056,645,990'Thiazolyl urea compounds and methods of uses'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003–2020Patents assigned to AMGEN INC (28)· patent assignee history
2003–2020Based in San Gabriel, CA, US· patent location history
2012–2014Patents assigned to LIU LONGBIN (7)· patent assignee history
2012–2014Patents assigned to NORMAN MARK H (7)· patent assignee history
2012–2014Patents assigned to SIEGMUND AARON C (6)· patent assignee history
2012–2014Patents assigned to BOOKER SHON (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AMGEN INC | 28 | 2003–2020 |
| LIU LONGBIN | 7 | 2012–2014 |
| NORMAN MARK H | 7 | 2012–2014 |
| SIEGMUND AARON C | 6 | 2012–2014 |
| BOOKER SHON | 5 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Gabriel, California, US | 29 | 2003–2020 |